Antibiotics

Clarithro-SBH

New generation antibiotic for the treatment of mycoplasma infections in poultry. Labelled a first in India.

PoultryPowder (feed mixing)Rx: prescription onlyUse under veterinary supervision

A 3-way treatment: clarithromycin acts against mycoplasma, serratiopeptidase reduces inflammation, and bromhexine hydrochloride thins mucus and reduces secretions.

CompositionEach gram contains

Clarithromycin IP	100 mg
Bromhexine hydrochloride IP	7.5 mg
Serratiopeptidase IP	2.5 mg

Indications

Mycoplasma gallisepticum
Mycoplasma synoviae
Staphylococci
Clostridia
Haemophilus influenzae
Campylobacter jejuni

Dosage

Through feed mixing for layers, broilers and breeders, for 5 to 7 days:

Chick stage (1–4 weeks): 150 g per tonne of feed
Chick stage (4–8 weeks): 250 g per tonne of feed
Growers to pre-laying stage (9–18 weeks): 500 g per tonne of feed
Adult layers, one week a month programme: 500 g per tonne of feed
Treatment in adult layers: 1.25–1.5 kg per tonne of feed
Treatment in layer breeders: 1.25–1.5 kg per tonne of feed
Treatment in broiler breeders: 3.0–3.25 kg per tonne of feed
Preventive schedule in layers and layer breeders: 250 g per tonne for 5 days at 4–6 weeks of age, and 500 g per tonne at 15–18 weeks

Caution. Therapeutic dose is 7.5 mg per kg body weight for 5 days, or as recommended by a Registered Veterinary Practitioner. Dosages are for reference only; the company is not responsible for any loss from use of the product without the recommendation and prescription of a Registered Veterinary Practitioner.

Pack sizes500 g

Advantages of Clarithro-SBH

New generation antibiotic against Mycoplasma spp.
Twice as powerful as azithromycin and tylvalosin
Faster absorption and quick action
Absorption is not affected by intake of feed or water
Tolerant to variable pH levels in the digestive tract
Higher volume of distribution in the blood
Higher percentage of active drug circulating in the blood
Deep penetration at the site of infection
Serum half-life above the MIC50 level
Higher serum concentration
Drug elimination time of around 3.44 hours
Low dosage of 7.5 mg per kg body weight per day
No resistance reported

Serratiopeptidase advantages

Anti-inflammatory, analgesic and anti-oedema action
Reduces inflammation by blocking chemical messengers, and increases antibiotic penetration and micro-circulation at the site of infection
Increases the effectiveness of antibiotics by four times
Dissolves dead and damaged tissue and starts quick healing
Helps bring immune cells to damaged tissue
Reduces oedema, nasal discharge, facial swelling, swollen wattles, sinuses, foot dermatitis and gangrenous dermatitis